1. Langsteger W. EANM 2010—Welcome to Vienna! Eur J Nucl Med Mol Imaging 2010;37 Suppl 2:S183–4.
2. European School of Nuclear Medicine Continuing Medical Education at the Annual Congress of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging 2010;37 Suppl 2:S191–7.
3. Aukema TS, Kappers I, Valdés-Olmos RA, Teerstra HJ, Schaake EE, Van Tinteren H, et al. 18F-FDG PET/CT and diagnostic CT for the prediction of histopathologic treatment response after epidermal growth factor receptor tyrosine kinase inhibitor treatment in patients with resectable NSCLC. Eur J Nucl Med Mol Imaging 2010;37 Suppl 2:OP228.
4. Capriotti G, Tabbi L, Pizzichini P, Prosperi D, Durante S, Papa A, et al. Radiofrequency ablation in lung cancer: comparison between contrast-enhanced CT and PET/CT. Eur J Nucl Med Mol Imaging 2010;37 Suppl 2:OP344.
5. Apostolopoulos DJ, Hohenberger P, Roumia S, Dimitrakopoulou-Strauss A, Strauss LG. The value of parametric F-18-FDG-PET images for the detection of liver metastases in patients with gastrointestinal stromal tumors under anti-proliferative and anti-angiogenic therapy. Eur J Nucl Med Mol Imaging 2010;37 Suppl 2:OP027.